Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01252953
Show Display Options
RSS Create an RSS feed from your search for:
NCT01252953
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
Condition: Atherosclerotic Cardiovascular Disease
Interventions: Drug: anacetrapib;   Drug: placebo anacetrapib

Indicates status has not been verified in more than two years